Literature DB >> 2272325

Human epidemiology: a review of fiber type and characteristics in the development of malignant and nonmalignant disease.

J A Merchant1.   

Abstract

Consideration of the human epidemiology of diseases arising from exposure to naturally occurring and man-made mineral fibers encompasses the several forms of asbestos (chrysotile, crocidolite, amosite, anthophyllite, tremolite-actinolite), other naturally occurring silicates (talc, sepiolite, erionite, attapulgite, vermiculite, and wollastonite), and man-made mineral fibers (glass continuous filament, glass/rock/slag insulation wools, ceramic and other refractory fibers, and glass microfibers). The diseases arising from exposures to some of these fibers include pleural thickening (plaques, diffuse pleural thickening, and calcification), pulmonary fibrosis, lung cancers, mesothelioma of the pleura and peritoneum, and other cancers). Risk factors important in assessing these diseases include assessment of latency, duration of exposure, cumulative exposure, fiber origin and characteristics (length and diameter), other possible confounding occupational or environmental exposures, and smoking. Methodological issues commonly presenting problems in evaluation of these data include assessment of the adequacy of environmental exposures, particularly in regard to fiber identification, distribution, and concentration over the duration of exposure, and the adequacy of study design to detect health effects (disease frequency, latency, and cohort size). Research priorities include further assessment and standardization of pleural thickening relative to fiber exposure, uniform mesothelioma surveillance, further epidemiological assessment of certain silicate and man-made mineral fiber cohorts with emphasis given to assessment of tremolite and small diameter glass and ceramic fibers. Further assessment of possible health risks of the general public should await improved definition of relevant fiber exposure in ambient air.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2272325      PMCID: PMC1567998          DOI: 10.1289/ehp.9088287

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  34 in total

1.  Exposure to asbestos and the risk of gastrointestinal cancer: a reassessment.

Authors:  D A Edelman
Journal:  Br J Ind Med       Date:  1988-02

2.  The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite: Part III. Radiographic findings.

Authors:  H E Amandus; R Althouse; W K Morgan; E N Sargent; R Jones
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

3.  The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite: Part II. Mortality.

Authors:  H E Amandus; R Wheeler
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

4.  The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite: Part I. Exposure estimates.

Authors:  H E Amandus; R Wheeler; J Jankovic; J Tucker
Journal:  Am J Ind Med       Date:  1987       Impact factor: 2.214

5.  A retrospective cohort mortality study of males mining and milling attapulgite clay.

Authors:  R J Waxweiler; R D Zumwalde; G O Ness; D P Brown
Journal:  Am J Ind Med       Date:  1988       Impact factor: 2.214

6.  Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey.

Authors:  I Baris; L Simonato; M Artvinli; F Pooley; R Saracci; J Skidmore; C Wagner
Journal:  Int J Cancer       Date:  1987-01-15       Impact factor: 7.396

7.  Radiological survey of past and present vermiculite miners exposed to tremolite.

Authors:  J C McDonald; P Sebastien; B Armstrong
Journal:  Br J Ind Med       Date:  1986-07

8.  Comparative epidemiology of men exposed to asbestos and man-made mineral fibers.

Authors:  J R Goldsmith
Journal:  Am J Ind Med       Date:  1986       Impact factor: 2.214

9.  US prevalence of occupational pleural thickening. A look at chest X-rays from the first National Health and Nutrition Examination Survey.

Authors:  W J Rogan; B C Gladen; N B Ragan; H A Anderson
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

10.  Asbestos-induced pleural fibrosis and impaired lung function.

Authors:  D A Schwartz; L J Fuortes; J R Galvin; L F Burmeister; L E Schmidt; B N Leistikow; F P LaMarte; J A Merchant
Journal:  Am Rev Respir Dis       Date:  1990-02
View more
  7 in total

1.  Radiological changes in asbestos cement workers.

Authors:  K Jakobsson; U Strömberg; M Albin; H Welinder; L Hagmar
Journal:  Occup Environ Med       Date:  1995-01       Impact factor: 4.402

2.  Perineal use of talcum powder and endometrial cancer risk.

Authors:  Stalo Karageorgi; Margaret A Gates; Susan E Hankinson; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

Review 3.  Asbestos-induced lung diseases: an update.

Authors:  David W Kamp
Journal:  Transl Res       Date:  2009-02-11       Impact factor: 7.012

4.  Biological effects of naturally occurring and man-made fibres: in vitro cytotoxicity and mutagenesis in mammalian cells.

Authors:  R Okayasu; L Wu; T K Hei
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

5.  Multipolar mitosis and aneuploidy after chrysotile treatment: a consequence of abscission failure and cytokinesis regression.

Authors:  Beatriz Araujo Cortez; Paula Rezende-Teixeira; Sambra Redick; Stephen Doxsey; Glaucia Maria Machado-Santelli
Journal:  Oncotarget       Date:  2016-02-23

6.  Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species.

Authors:  An Xu; Hongning Zhou; Dennis Zengliang Yu; Tom K Hei
Journal:  Environ Health Perspect       Date:  2002-10       Impact factor: 9.031

7.  Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.

Authors:  I A Mórocz; D Schmitter; B Lauber; R A Stahel
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.